Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 212 (RNA5SP212) is a processed pseudogene of the 5S ribosomal RNA gene[2][4][8]. Pseudogenes are genomic DNA sequences resembling functional genes, but typically carry mutations or truncations rendering them nonfunctional—they do not produce functional proteins or RNAs[8][2][6]. The 5S rRNA gene normally encodes a small, highly conserved component of the ribosome essential for protein synthesis, but pseudogenes derived from this gene—such as RNA5SP212—are non-functional relics that retain high sequence similarity yet lack coding capability or defined cellular function[4][8]. As a result, they are not considered valid molecular targets for therapeutics or biomarkers, and their presence is primarily of interest for genome annotation and evolutionary studies, not for disease or pharmacological intervention[2][4][8]. Note on correctness: This is not a canonical drug or receptor target, but a pseudo-gene annotation. The use of “RNA5SP212” as a drug/receptor/therapeutic target is incorrect[4][2][8].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 212 (RNA5SP212).